PALB2 and breast cancer: Disease-associated variants in PALB2 are rare in the UK population, with only approximately 1% of familial breast cancer being attributable to mutations in this gene, whereas 1% of all breast cancer in Finland is due to a single mutation (1592delT) in PALB2 [12].